Aphria Inc reported CAD74.04M in Selling and Administration Expenses for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Ani Pharmaceuticals ANIP:US $ 18.82M 1.23M
Aurora Cannabis Inc ACB:CN 46.92M 1.04M
Canopy Growth Corp WEED:CN C$ 111.05M 38.77M
Corcept Therapeutics CORT:US $ 30.03M 520K
Cronos Group Inc CRON:CN 38.19M 3.53M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Lannett LCI:US $ 21.58M 3.94M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Supernus Pharmaceuticals SUPN:US $ 69.54M 8.08M